In order to widely integrate nanotechnology, cancer research and molecular biomedicine, the National Cancer Center (NCI) proposed the Cancer Nanotechnology Plan (Cancer Nanotechnology Plan), which will be implemented through out-of-hospital, in-hospital, and nanotechnology standard laboratories. Cross-disciplinary work in three areas. The plan sets six challenges:
Prevent and control cancer: develop nano-scale equipment that can deliver anti-cancer drugs and multiple anti-cancer vaccines.
Early detection and proteology: develop implantable early detection of cancer biomarkers, and develop a platform device that can collect a large number of biomarkers for a large amount of analysis.
Imaging diagnosis: Development of imaging devices that can increase the resolution to identify individual cancer cells, and nanodevices that can distinguish cells from different tissues within a tumor.
Multifunctional therapeutic equipment: develop nanodevices that combine diagnosis and treatment.
Cancer care and improvement of quality of life: develop and improve symptoms such as pain, depression, and nausea caused by chronic cancer, and provide ideal drug delivery devices.
Cross-field training: Train a new generation of researchers familiar with cancer biology and nanotechnology.